VecTech
Techstars '23Baltimore, US · Founded 2019 · 20 employees on LinkedIn · 2 known investors
Find your way into VecTech
Sign up to see every warm intro you have to VecTech
- Paths you didn't know you had: your email and LinkedIn already hold routes to the VecTech team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Vectech develops AI-powered vector identification and surveillance technologies to support public health interventions and targeted mosquito control during disease outbreaks. The company serves public health organizations and disease prevention agencies globally.
Also known as Vectech · Vectech, Inc. · Vectech, LLC
Founders & leadership
VecTech was founded in 2019 by Tristan Ford, Meg Glancey, and Autumn Goodwin.

Investors · 2
How we know: the company's own site · the Techstars portfolio · open dataset · Top 3000 Accelerator Startups (no YC) 2026-08 · Not right? Tell us
Also in the syndicate · 1
Company profile
researched Sep 2026Vectech is a Baltimore, Maryland-based public benefit corporation founded in 2019 that develops AI-powered vector identification and surveillance technology. Its platform applies optics, imaging hardware and computer vision to identify insect specimens, covering more than 70 mosquito species and more than 30 tick species. The company positions species-level identification as a prerequisite for early threat detection and for tailoring mosquito-control interventions and community response.
The company was founded out of Johns Hopkins University, originating from a USAID Grand Challenge grant aimed at the Zika epidemic. Its interdisciplinary staff includes engineers, computer scientists, public-health specialists and entomologists, with in-house software, computer vision, optics and entomology functions. Leadership includes co-founder and CEO Tristan Ford, co-founder and CTO Autumn Goodwin, and co-founder and advisor Meg Glancey; other roles span technical product management, software engineering, mechanical engineering, full-stack development, computer vision engineering and entomology. Products include IDX, a vector identification tool, alongside Internet-of-Things data acquisition devices and low-cost imaging systems for remote mosquito surveillance.
Vectech also maintains an active research program, collaborating with mosquito control districts, NGOs and research institutions, and publishing on computer vision, data cleaning methods and mosquito and tick identification in journals including Scientific Reports, Biomedical Optics Express, Acta Tropica, Frontiers in Tropical Diseases and the Journal of the American Mosquito Control Association.
Founding story
Vectech was founded in 2019 out of Johns Hopkins University, originating from a USAID Grand Challenge grant awarded to combat the Zika epidemic. The initial response to that outbreak developed into a broader effort to enable fast, accurate insect species identification supporting targeted mosquito control during disease outbreaks. Co-founders include Tristan Ford (CEO), a biomedical engineer and Gates Millennium Scholar and David L. Boren fellow with degrees from the University of Rochester and Johns Hopkins; Autumn Goodwin (CTO), an engineer specializing in applied optics and computer vision who is lead inventor and principal investigator on several core technologies; and Meg Glancey, an epidemiologist who previously managed over $1.5M in global innovation research funding at Johns Hopkins University and now advises the company.
Business model
Vectech sells AI-based insect identification and surveillance technology to organizations that conduct vector surveillance, combining imaging hardware, Internet-of-Things data acquisition devices and computer vision models deployed to customers. It also pursues collaborative research with mosquito control districts, NGOs and research institutions, and has been supported by grant funding, including its founding USAID Grand Challenge grant.
Public materials reference first sales and partnerships around the launch of the company's first product, alongside grant-supported research and development.
Traction
Vectech states its product is used worldwide by mosquito control districts, public-health organizations and research institutions. It reported first sales and partnerships ahead of its first product launch in early 2023, has published peer-reviewed research from 2020 through 2025, and reports over 95% model accuracy across 70+ mosquito and 30+ tick species.
Latest developments
In 2025 Vectech-affiliated researchers published TaxoAttention, a taxonomy- and attention-based approach to mosquito identification (TechRxiv, October 2025), and work on West Nile virus surveillance in Maryland integrating smart vector identification with environmental and epidemiological data in the Journal of the American Mosquito Control Association (December 2025). The company's site advertises identification coverage of 70+ mosquito species and 30+ tick species, with ongoing development of tick detection and identification.
▸Full profile — market position, technology, go-to-market, geography, history
Market position
Vectech describes its system as the first AI system designed for mosquito and tick species identification, and lists support or collaboration associations with organizations including NSF, the National Institutes of Health, WRBU, AMCA, CDC, USDA, KEMRI, REDI-NET, Navy Entomology, the Smithsonian, DWFP and the Department of Defense.
The company combines purpose-built imaging hardware with species-level classification models spanning both mosquitoes and ticks, aiming to lower surveillance costs, reduce the entomological training required for accurate identification, and produce more standardized species data for public health programs.
Technology
The company builds optics and imaging systems paired with computer vision and machine learning models for insect detection and species classification. Its stated models cover 70+ mosquito species and 30+ tick species with reported accuracy over 95% on global surveillance datasets. Published work spans convolutional neural networks with a multitiered ensemble model for novel species detection, an Ordered Sample Consensus (ORSAC) data-cleaning method for identifying probable mislabeled data, taxonomy-aware attention models (TaxoAttention), a low-cost imaging system for remote mosquito surveillance, and the IDX vector identification tool. Supporting engineering covers firmware, backend and frontend for IoT data acquisition products and deployment of computer vision models.
Go-to-market
Vectech reaches customers directly through its own site and sales outreach, supported by research collaborations with mosquito control districts, NGOs and research institutions, peer-reviewed publications and conference presentations, and participation in accelerator programs including MassChallenge Switzerland 2021 and Techstars Equitech 2023.
Mosquito control districts and control organizations, public health and global health agencies, and academic and research institutions.
Geography
Headquartered in Baltimore, Maryland, with products reported in use worldwide by mosquito control districts, public health organizations and research institutions; the company also participated in an accelerator program based in Switzerland.
History
The company was founded in 2019 as a Johns Hopkins University spinout from a USAID Grand Challenge grant. In 2020 it published its smart-traps imaging approach in Biomedical Optics Express and received a $150,000 pre-seed investment through the Maryland Innovation Initiative, announced in August 2020 when the company operated as Vectech, LLC. It was subsequently selected for the MassChallenge Switzerland 2021 Accelerator, later converted to a public benefit corporation, and in January 2023 announced it had joined the Techstars Equitech Accelerator Class of 2023 in Baltimore while preparing to launch its first product on the back of early sales and partnerships.
Compiled by commissioned research from 8 cited public sources — announcements, filings, and press listed under research sources below.
Key figures
latest reportedCompany-reported or press-reported figures, each dated to when it was claimed — not independently audited.
Non-dilutive funding · 8 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| Centers for Disease Control and Prevention (CDC)Centers for Disease Control and Prevention | Phase II | 2023 | $2M |
| National Science Foundation | Phase II | 2023 | $999.5K |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2023 | $950.4K |
| Department of Agriculture (USDA) | Phase II | 2022 | $649.8K |
| Centers for Disease Control and Prevention (CDC)Centers for Disease Control and Prevention | Phase I | 2022 | $298.7K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2021 | $350.7K |
| National Science Foundation | Phase I | 2021 | $255.8K |
| Department of Agriculture (USDA) | Phase I | 2021 | $100K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Timeline · 5
launches, deals, and filingsVectech, Inc. announced it would join the Techstars Equitech Accelerator Class of 2023, run in collaboration with UpSurge Baltimore. Ten companies were selected from hundreds of applicants at a selection rate of under 3%.
Vectech, previously organized as Vectech, LLC, converted to a public benefit corporation and is described as Vectech, Inc., a Baltimore-based public benefit corporation.
Vectech announced a $150,000 pre-seed investment through the Maryland Innovation Initiative program, one of six companies MII invested in that round. The company said the funding would address technical challenges in applying computer vision to entomological workflows and accelerate its path to market.
$150K source ↗
The company published "Development of a low-cost imaging system for remote mosquito surveillance" in Biomedical Optics Express (2020), 11(5), 2560-2569.
Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.
▸Research sources · 8
primary sources listed
- VecTechvectech.io · web
8 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does VecTech do?
- Vectech builds AI imaging and computer-vision systems that identify mosquito and tick species for vector surveillance programs.
- Who founded VecTech?
- VecTech was founded by Tristan Ford, Meg Glancey, Autumn Goodwin in 2019.
- Who are VecTech's investors?
- VecTech's investors include Techstars.
- Where is VecTech headquartered?
- VecTech is headquartered in Baltimore, US.


